PMP22 and Charcot-Marie-Tooth disease type 1A: In addition, our study confirms a role of ER stress in the pathogenesis of CMT1A and demonstrate the ability of IFB-088 to assist the ER-stress response to the over-expression of PMP22 and potentially treat patients with CMT1A.